BS

Baljeet Singh Talwar

Active Director Director DIN 02296323
DIN 02296323 First appointment Jun 1994 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 4 active board seats
Past companies 5 historical roles
Total affiliations 9 Since Jun 1994
Shareholding value •••• Premium profile

About Baljeet Singh Talwar

Data last updated:

Baljeet Singh Talwar is a Director at Cure Aim Healthcare Private Limited (since 2009), Designated Partner at Nystara Naturals Llp (since 2025) and Director at Imp India Private Limited (since 1994), and holds 1 more current directorship. The companies operate in Pharma, Trading and Education. The largest current company by reported revenue is Cure Aim Healthcare Private Limited at ₹37,746 (FY 2024). Earlier, Baljeet Singh Talwar was a Director at Shradha Nirman Private Limited (2024–2025) and Director at Wave Pharmaceuticals Limited (1997–2018) and 3 more.

DIN 02296323
Primary Designation Director
Industry Pharma
First Appointment 14 Jun 1994
Oldest Company Age 32 yrs
Largest company Cure Aim Healthcare Private Limited · ₹37,746 (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Cure Aim Healthcare Private Limited U51397DL2003PTC118622
Director01 Jun 20092003₹37,746 (FY 2024)Active
Designated Partner28 Jul 20252025Active
Imp India Private Limited U74999DL1994PTC060664
Director03 Aug 19941994Active
Wave International Limited U74899DL1994PLC059606
Director14 Jun 19941994Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Shradha Nirman Private Limited U25209DL1998PTC094036
Director01 Apr 20241998₹2.16 Cr (FY 2025)Active
Wave Pharmaceuticals Limited U24231DL1997PLC088998
Director08 Aug 19971997₹1.93 Cr (FY 2023)Active
Zed Leafin Private Limited U74899DL1995PTC073807
Director13 Nov 19951995₹6.80 Cr (FY 2025)Active
Wave Laboratories Lmited U74899DL1995PLC073725
Director09 Nov 19951995Strike Off
Kenabel Solutions Limited U72200DL1996PLC081681
Director04 Sep 19961996Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Wave Laboratories Lmited
Imp India Private Limited
Cure Aim Healthcare Private Limited
Kenabel Solutions Limited
Premium access

Shareholding and investment profile for Baljeet Singh Talwar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Baljeet Singh Talwar

Baljeet Singh Talwar currently holds 4 directorships: Cure Aim Healthcare Private Limited (Director, since 01 Jun 2009, revenue ₹37,746 (FY 2024)); Nystara Naturals Llp (Designated Partner, since 28 Jul 2025); Imp India Private Limited (Director, since 03 Aug 1994); Wave International Limited (Director, since 14 Jun 1994).

Baljeet Singh Talwar was first appointed on 14 Jun 1994 as Director at Wave International Limited. The most recent appointment on record is 28 Jul 2025 at Nystara Naturals Llp.

Baljeet Singh Talwar held 5 earlier board appointments: Shradha Nirman Private Limited (Director, 01 Apr 2024 to 30 Sep 2025); Wave Pharmaceuticals Limited (Director, 08 Aug 1997 to 10 Feb 2018); Zed Leafin Private Limited (Director, 13 Nov 1995 to 27 Sep 2017); Wave Laboratories Lmited (Director, from 09 Nov 1995); Kenabel Solutions Limited (Director, from 04 Sep 1996).

The current boards of Baljeet Singh Talwar's companies include Aashish Oberai (Cure Aim Healthcare Private Limited), Diwaker Mishra (Cure Aim Healthcare Private Limited), Vinay Kumar Singh (Cure Aim Healthcare Private Limited), Amarjit Kaur Talwar (Nystara Naturals Llp), Vijay Kumar Matta (Imp India Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available